Clinical Trials Logo

Metabolic Disease clinical trials

View clinical trials related to Metabolic Disease.

Filter by:

NCT ID: NCT02529228 Completed - Clinical trials for Cardiovascular Disease

Combined Effects of Meal Frequency and Protein Load on Cardiometabolic Risk Factors

Start date: December 2014
Phase: N/A
Study type: Interventional

This study examines the effect of meal frequency and meal composition on risk factors of cardiometabolic disease.

NCT ID: NCT02153983 Completed - Obesity Clinical Trials

Effects of Colchicine in Non-Diabetic Adults With Metabolic Syndrome

Start date: May 31, 2014
Phase: Phase 1/Phase 2
Study type: Interventional

Background: - Being overweight may cause low-level inflammation. This inflammation may cause some of the medical problems of obesity, like high blood sugar (diabetes) and heart disease. This study will test whether a medication called colchicine can improve metabolism in adults who are overweight but have not yet developed diabetes. Objectives: - To learn whether colchicine improves sugar regulation and metabolism. Eligibility: - Healthy overweight adults18 to 100 years old. Design: - Participants must fast before each visit, including the screening visit. - Participants will be screened with blood tests,urine tests, medical history, and physical exam. They will have to drink sugar water, and have blood drawn to find out if they are healthy. - For visit 1, participants will have a medical history and physical exam and answer questions. They will have blood taken with an intravenous (IV) line, give urine sample, and give 2 stool samples.. - Also, subjects will get sugar water through one IV. Blood will be drawn from the other. This measures sugar and insulin levels. During this, participants will lie in a bed and can watch TV. - Participants will have a full-body X-ray, lying on a table while a camera passes over them. They will also have an abdominal CT scan, lying on a table that moves through a ring that takes pictures. - Participants will have a small fat tissue sample taken from their abdomen. It is like getting a mini-liposuction. - Participants will be given the study drug or placebo. They will take it twice daily for 3 months. - For visit 2, participants will have blood tests, urine tests, medical history, and physical exam. - For visit 3, participants will repeat the tests in visit 1.

NCT ID: NCT02019667 Completed - Metabolic Disease Clinical Trials

Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency

Start date: March 31, 2014
Phase: Phase 2
Study type: Interventional

Objective: To perform a clinical trial assessing the safety, tolerability and efficacy of the GABA(B) receptor antagonist SGS-742 in patients with SSADH deficiency. Study Population: Twenty-two children and adults with SSADH deficiency. Design: Double-blind, cross-over, phase II clinical trial. Outcome Measures: The primary outcome measures for drug efficacy will be performance on neuropsychological testing and responses to parent questionnaire. The secondary outcome measure will be TMS parameters of cortical excitation and inhibition. The outcome measures for safety will include clinical examination and neuropsychological tests.

NCT ID: NCT01778569 Completed - Inflammation Clinical Trials

The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)

Start date: January 22, 2013
Phase:
Study type: Observational

Background: - Cardiometabolic diseases are medical disorders that can occur together and affect the heart. They increase the risk of developing heart disease and diabetes. One disorder, psoriasis, is an inflammation that mostly affects the skin but can affect the entire body. Another disorder, atherosclerosis, is a process in which cholesterol is gradually deposited on the wall of arteries. This causes arteries to harden and become less flexible. Many cells that cause psoriasis also cause atherosclerosis. Researchers want to look at the relationship between cardiometabolic diseases and psoriasis. Objectives: - To study the relationship between psoriasis and cardiometabolic diseases. Eligibility: - Individuals at least 18 years of age who have psoriasis. Design: - Participants will be screened with a physical exam and medical history. - Participants will have up to seven outpatient visits over the 4 years. The first visit will be a screening visit. Visits 2 will be12 months after visit 1. Visits 3, 4, and 5, will be scheduled yearly for the next 3 years. If participants have a psoriasis flare with more severe symptoms, they may have an extra visit. Those who leave the study early will have a final visit with the full series of tests. - At visits 1, 2,and 5, and any flare visits, participants will have a physical exam and medical history. They will provide blood and urine samples, as well as optional tissue biopsies. They will also have heart function tests. Imaging studies, as well as optional photographs of affected areas, will be performed. These tests will also be performed at the final visit. - At visits 3 and 4, participants will have a physical exam and medical history. They will also provide blood and urine samples, and have heart function tests.

NCT ID: NCT01692860 Completed - Sarcopenia Clinical Trials

Effects of Milk Protein Concentrate on Overall Health During Weight Loss in Overweight/Obese Adults

S28
Start date: January 2012
Phase: N/A
Study type: Interventional

. The purpose of this study is to examine the effects of eating a larger amount of dairy-based protein on risk factors for metabolic syndrome

NCT ID: NCT01686828 Completed - Obesity Clinical Trials

T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin

T-IR
Start date: June 2013
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this research study is to understand the effects of testosterone and estrogen on the body's response to the hormone insulin.

NCT ID: NCT01457612 Completed - Insulin Resistance Clinical Trials

Effect of 6-week Strawberry Supplementation on Insulin Action (STR2)

Start date: October 1, 2011
Phase: N/A
Study type: Interventional

The primary study objective is to investigate the potential chronic beneficial effect of polyphenolics derived from strawberry on impaired insulin signaling in insulin resistant individuals through their ability to modulate oxidative- and inflammatory-markers that lead to devastating disease, including, but not limited to, diabetes and cardiovascular disease.

NCT ID: NCT01450592 Completed - Diabetes Mellitus Clinical Trials

Study To Assess the Dietary Carbohydrate Content of Indian Diabetic Population

STARCH
Start date: May 2012
Phase: N/A
Study type: Observational

The study is designed as an interventional (as blood investigations will be done) dietary survey of diabetic & non-diabetic population sample of India to understand & compare dietary patterns among them.The study objective is to find out amount of carbohydrate content of daily diet of diabetic population study . This study does not intend to study the effect of any drugs. There will be 2 groups : Type 2 diabetics and non diabetic population. The study will begin after the study approval by ethics committee. The subject will involved after they sign the consent form. The study involves general examination of patients, collection of data like history of disease, interview by dietitian with the help of questionnaire, blood investigations (only in diabetic population only) and glycaemic control status of only diabetic population.The study is planned to be enroll 800 subjects (400 in each groups) from 10 study centers spread across India. The study data will be analyzed with appropriate statistical methods.

NCT ID: NCT01443806 Completed - Metabolic Disease Clinical Trials

Characterisation of the Human Carboxylesterase 1 (CES1) Mutations in Thailand

Start date: July 2011
Phase: Phase 4
Study type: Interventional

The aim of this study is to evaluate the conversion of OP to OC in individual X and the family member of individual X. The investigators hypothesize that one or more of the single nucleoprotein polymorphisms (SNPs) of the CES1 gene represent a clinically important functional polymorphism.

NCT ID: NCT00475774 Completed - Obesity Clinical Trials

Body Fat Distribution and Fat Metabolism

Start date: May 2007
Phase: N/A
Study type: Interventional

The primary purpose of the study is to examine the effect of body fat distribution on the physiological response to a dietary fat intervention. Physiological response will be evaluated as fatty acid kinetics (plasma and subcutaneous fat appearance). Secondary objectives are targeted protein production (apoB and adiponectin). Examination of the effect of chain length of the dietary fatty acids on fat tissue characteristics and the effect of chain length on satiety, will be studied as well.